Douglas D. O'Bannon - Concepedia

Author

Douglas D. O'Bannon

Also Known As

D. D. O'Bannon, D. O'BANNON, D.D. O’Bannon, Douglas D. O'Bannon, Douglas D. O'bannon, Douglas D. O’Bannon, Douglas O'Bannon, Douglas O’Bannon

Publications

124

Citations

H-Index

Concepts

All Affiliations

Douglas D. O'Bannon is an author at Eli Lilly (United States) specializing in medicine, pharmacology, and drug discovery.

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	49
2	Biochemistry	2	2	24
3	Natural Sciences	1	1	10
4	Cell Biology	1	1	14
5	Metabolism	1	1	14

Douglas D. O'Bannon

Publications

Citations

H-Index

Page 1

	Year	Citations
Synthesis of [11C]dapoxetine · HCl, a serotonin re-uptake inhibitor: Biodistribution in rat and preliminary PET imaging in the monkey Eli Livni, W. Satterlee, Roger L. Robey, Nuclear Medicine and Biology Positron Emission TomographyPharmacological StudySerotonin Re-uptake InhibitorMedicinePreliminary Pet Imaging	1994	25
IN VIVO METABOLISM OF [14C]RUBOXISTAURIN IN DOGS, MICE, AND RATS FOLLOWING ORAL ADMINISTRATION AND THE STRUCTURE DETERMINATION OF ITS METABOLITES BY LIQUID CHROMATOGRAPHY/MASS SPECTROMETRY AND NMR SPECTROSCOPY Robert J. Barbuch, Kristina Campanale, Chad E. Hadden, Drug Metabolism and Disposition	2005	15
Disposition of LY333531, a selective protein kinase C<i>β</i>inhibitor, in the Fischer 344 rat and beagle dog Jennifer Burkey, K. M. Campanale, Douglas D. O'Bannon, Xenobiotica Gastrointestinal PharmacologyDigestive TractFischer 344Molecular PharmacologyMale Fischer 344	2002	14
Disposition of [14C]Ruboxistaurin in Humans Jennifer Burkey, Kristina Campanale, Robert J. Barbuch, Drug Metabolism and Disposition	2006	13
A chiral synthesis of dapoxetine hydrochloride, a serotonin reuptake inhibitor, and its <sup>14</sup>C isotopomer William J. Wheeler, Douglas D. O'Bannon Journal of Labelled Compounds and Radiopharmaceuticals Organic ChemistryPharmaceutical ChemistryChiral SynthesisDapoxetine HydrochlorideMolecular Pharmacology	1992	10

Page 1